NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Zennami Kenji
Fujita Health University - Toyoake / Japan
Others
AD Scientific Index ID: 5285666
藤田保健衛生大学
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Zennami Kenji's MOST POPULAR ARTICLES
1-)
Increased infiltration of CCR4‐positive regulatory T cells in prostate cancer tissue is associated with a poor prognosisM Watanabe, K Kanao, S Suzuki, H Muramatsu, S Morinaga, K Kajikawa, ...The prostate 79 (14), 1658-1665, 2019582019
2-)
Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridizationH Matsubara, Y Yamada, K Naruse, K Nakamura, S Aoki, T Taki, ...Oncology reports 19 (1), 57-63, 2008492008
3-)
Targeting lactate dehydrogenase‑A promotes docetaxel‑induced cytotoxicity predominantly in castration‑resistant prostate cancer cellsH Muramatsu, M Sumitomo, S Morinaga, K Kajikawa, I Kobayashi, ...Oncology reports 42 (1), 224-230, 2019392019
4-)
Management of adverse events in patients with metastatic renal cell carcinoma treated with sunitinib and clinical outcomesM Arakawa-Todo, T Yoshizawa, K Zennami, G Nishikawa, Y Kato, ...Anticancer research 33 (11), 5043-5050, 2013392013
5-)
PDCD4 is an androgen-repressed tumor suppressor that regulates prostate cancer growth and castration resistanceK Zennami, SM Choi, R Liao, Y Li, W Dinalankara, L Marchionni, ...Molecular Cancer Research 17 (2), 618-627, 2019362019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept